Sirtuin 1 regulates lipid metabolism associated with optic nerve regeneration

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 6962-6968

  Zhang, Yan ^a   Li, Hongyang ^a   Cao, Yongmei ^b   Zhang, Maonian ^a   Wei, Shihui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b International Mongolion Hospital   (China)

Author keywords

Cholesterol regulatory element binding protein 2; Cholesterol synthesis; Optic nerve damage; Retinal ganglion cells; Sirtuin 1

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; RESVERATROL; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; LIMIT OF QUANTITATION; LIPID METABOLISM; MALE; NERVE REGENERATION; NONHUMAN; OPTIC NERVE; OPTIC NERVE LESION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; RAT MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; WESTERN BLOTTING; ANIMAL; GENETICS; METABOLISM; OPTIC NERVE INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; MALE; NERVE REGENERATION; OPTIC NERVE; OPTIC NERVE INJURIES; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 84943598962     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4286     Document Type: Article

References (31)

1. Pernet V and Schwab ME: Lost in the jungle: New hurdles for optic nerve axon regeneration. Trends Neurosci 37: 381-387, 2014.
2. Pernet V, Hauswirth WW and Di Polo A: Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem 93: 72-83, 2005.
3. Goldberg JL, Klassen MP, Hua Y and Barres BA: Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296: 1860-1864, 2002.
4. Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, Lemmon VP and Goldberg JL: KLF family members regulate intrinsic axon regeneration ability. Science 326: 298-301, 2009.
5. Schwab ME: Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 11: 799-811, 2010.
6. Yiu G and He Z: Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7: 617-627, 2006.
7. Guarente L and Franklin H: Epstein lecture: Sirtuins, aging and medicine. N Engl J Med 364: 2235-2244, 2011.
8. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P and Auwerx J: AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060, 2009.
9. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al: Stressdependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004.
10. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM and Puigserver P: Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118, 2005.
11. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD and Garcia JA: Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324: 1289-1293, 2009.
12. Michan S: Acetylome regulation by sirtuins in the brain: From normal physiology to aging and pathology. Curr Pharm Des 19: 6823-6838, 2013.
13. Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, Allard JS, Lewis K, Miller M, Xu W, et al: SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 30: 9695-9707, 2010.
14. Donmez G, Wang D, Cohen DE and Guarente L: SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142: 320-332, 2010.
15. Jiang M, Wang J, Fu J, Du L, Jeong H, West T, Xiang L, Peng Q, Hou Z, Cai H, et al: Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 18: 153-158, 2011.
16. Donmez G, Arun A, Chung CY, McLean PJ, Lindquist S and Guarente L: SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci 32: 124-132, 2012.
17. Guarani V, Deflorian G, Franco CA, Krüger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, et al: Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 473: 234-238, 2011.
18. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, et al: SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21: 2644-2658, 2007.
19. Chen J, Michan S, Juan AM, Hurst CG, Hatton CJ, Pei DT, Joyal JS, Evans LP, Cui Z, Stahl A, et al: Neuronal sirtuin1 mediates retinal vascular regeneration in oxygen-induced ischemic retinopathy. Angiogenesis 16: 985-992, 2013.
20. Michan S, Juan AM, Hurst CG, Cui Z, Evans LP, Hatton CJ, Pei DT, Ju M, Sinclair DA, Smith LE and Chen J: Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy. PLoS One 9: e85031, 2014.
21. Jiao X, Peng Y and Yang L: Minocycline protects retinal ganglion cells after optic nerve crush injury in mice by delaying autophagy and upregulating nuclear factor-κB2. Chin Med J (Engl) 127: 1749-1754, 2014.
22. Bazan NG: Homeostatic regulation of photoreceptor cell integrity: Significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: The proctor lecture. Invest Ophthalmol Vis Sci 48: 4866-4881, 2007.
23. Bazan NG, Birkle DL and Reddy TS: Biochemical and nutritional aspects of the metabolism of polyunsaturated fatty acids and phospholipids in experimental models of retinal degeneration. In: Retinal Degeneration: Experimental and Clinical Studies. LaVail MM, Hollyfield JG and Anderson RE (eds). Vol 2. A-R. Liss, New York, NY, pp159-187, 1985.
24. Scott BL and Bazan NG: Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci USA 86: 2903-2907, 1989.
25. Gordon WC, Rodriguez de Turco EB and Bazan NG: Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis. Curr Eye Res 11: 73-83, 1992.
26. Hoffman DR, Boettcher JA and Diersen-Schade DA: Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 81: 151-158, 2009.
27. Anderson RE, Maude MB and Bok D: Low docosahexaenoic acid levels in rod outer segment membranes of mice with rds/peripherin and P216L peripherin mutations. Invest Ophthalmol Vis Sci 42: 1715-1720, 2001.
28. Gordon WC and Bazan NG: Mediator lipidomics in ophthalmology: Targets for modulation in inflammation, neuroprotection and nerve regeneration. Curr Eye Res 38: 995-1005, 2013.
29. Bretillon L, Thuret G, Grégoire S, Acar N, Joffre C, Bron AM, Gain P and Creuzot-Garcher CP: Lipid and fatty acid profile of the retina, retinal pigment epithelium/choroid and the lacrimal gland and associations with adipose tissue fatty acids in human subjects. Exp Eye Res 87: 521-528, 2008.
30. Acar N, Berdeaux O, Grégoire S, Cabaret S, Martine L, Gain P, Thuret G, Creuzot-Garcher CP, Bron AM and Bretillon L: Lipid composition of the human eye: Are red blood cells a good mirror of retinal and optic nerve fatty acids? PLoS One 7: e35102, 2012.
31. Kabasawa S, Mori K, Horie-Inoue K, Gehlbach PL, Inoue S, Awata T, Katayama S and Yoneya S: Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology 118: 1082-1088, 2011.